Hunter syndrome overview: Difference between revisions
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Hunter syndrome is a [[lysosomal storage disease]] caused by a deficient (or absent) [[enzyme]], [[iduronate-2-sulfatase]] (I2S). | Hunter syndrome is a [[lysosomal storage disease]] caused by a deficient (or absent) [[enzyme]], [[iduronate-2-sulfatase]] (I2S). | ||
==Historical Perspective== | ==Historical Perspective== |
Revision as of 04:46, 26 February 2013
Hunter syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hunter syndrome overview On the Web |
American Roentgen Ray Society Images of Hunter syndrome overview |
Risk calculators and risk factors for Hunter syndrome overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hunter syndrome is a lysosomal storage disease caused by a deficient (or absent) enzyme, iduronate-2-sulfatase (I2S).
Historical Perspective
The syndrome is named after physician Charles A. Hunter (1873-1955), who first described it in 1917. Born in Scotland, Hunter emigrated to Canada and had a medical practice in Winnipeg, Manitoba.